The reduction in hyperglycemia observed in HFD-fed rats treated with exosomes could be due to increased insulin sensitivity, potentially through the modulation of AKT phosphorylation levels and enhanced glucose uptake in AML12 cells (Lei et al., 2021). Here, AKT1 is linked to Hyperglycemia.